EP3463469
COMBINATION OF LEDIPASVIR AND SOFOSBUVIR FOR USE IN THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS IN HUMANS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.5.2017EP published:
13.12.2023EP application number:
17725086.7
EPO information:
European Patent Register
Max expiry date:
10.5.2037
Title in English:
COMBINATION OF LEDIPASVIR AND SOFOSBUVIR FOR USE IN THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS IN HUMANSLanguage of the patent:
English
Timeline
Today
11.5.2017EP application
13.12.2023EP Publication
Owner
Name:
Gilead Sciences, Inc.Address:
333 Lakeside Drive, Foster City, CA 94404, US
Inventor
Name:
GAGGAR, AnujAddress:
Foster City, CA 94404, US
Name:
SUBRAMANIAN, G., ManiAddress:
Foster City, CA 94404, US
Priority
Number:
201662342787 PDate:
27.5.2016Country:
US
Classification
Categories:
A61K 45/06, A61K 31/454, A61K 31/498, A61K 31/675, A61K 31/7072, A61P 31/14